Turkish Industry Claims Fixed Euro Has Cost $7bn
This article was originally published in PharmAsia News
Executive Summary
The leading Turkish pharmaceutical industry association has published a report covering the 2009-14 period that is highly critical of the government’s price policies and estimates the cost to the industry of the fixed Euro rate at more than $7 billion.